DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Pollack Jr CV, Reilly PA, van Ryn J. , et al.
Idarucizumab for dabigatran reversal - full cohort analysis.
N Engl J Med 2017;
377 (05) 431-441
We do not assume any responsibility for the contents of the web pages of other providers.